Cargando…
Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer
The tumor microenvironment (TME) plays an important regulatory role in the progression of non-small cell lung cancer (NSCLC). Mesenchymal stem cells (MSCs) in the TME might contribute to the occurrence and development of cancer. This study evaluates the role of differentially expressed genes (DEGs)...
Autores principales: | Guo, Qiang, Xiao, Xiao-Yue, Wu, Chuang-Yan, Li, Dan, Chen, Jiu-Ling, Ding, Xiang-Chao, Cheng, Chao, Chen, Chong-Rui, Tong, Song, Wang, Si-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912942/ https://www.ncbi.nlm.nih.gov/pubmed/35281822 http://dx.doi.org/10.3389/fgene.2022.823075 |
Ejemplares similares
-
The Effects of Mesenchymal Stem Cells on Oral Cancer and Possible Therapy Regime
por: Yang, Tong, et al.
Publicado: (2022) -
An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma
por: Zhou, Xuan, et al.
Publicado: (2022) -
Transcriptomic and immunologic implications of the epithelial–mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma
por: Li, Na, et al.
Publicado: (2022) -
Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer
por: Miao, Ti-Wei, et al.
Publicado: (2022) -
RUNX regulated immune-associated genes predicts prognosis in breast cancer
por: Fu, Jingyue, et al.
Publicado: (2022)